Zhejiang Tailin Bioengineering Co Ltd (300813) — Working Capital to Net Assets Ratio
Zhejiang Tailin Bioengineering Co Ltd (300813) has a Working Capital to Net Assets ratio of 51.4% as of March 2026. Working capital of CN¥414.14 Million (current assets of CN¥552.05 Million minus current liabilities of CN¥137.91 Million) is measured against net assets of CN¥806.45 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See debt-free asset ratio of Zhejiang Tailin Bioengineering Co Ltd to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Zhejiang Tailin Bioengineering Co Ltd Working Capital to Net Assets (2013–2025)
This chart shows how Zhejiang Tailin Bioengineering Co Ltd's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the ratio stands at 51.4%, reflecting working capital of CN¥414.14 Million against net assets of CN¥806.45 Million CNY. Check Zhejiang Tailin Bioengineering Co Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Zhejiang Tailin Bioengineering Co Ltd (2013–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Zhejiang Tailin Bioengineering Co Ltd from 2013 to 2025, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Zhejiang Tailin Bioengineering Co Ltd market cap and net worth.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 49.4% | CN¥397.71 Million | CN¥804.29 Million | CN¥549.85 Million | CN¥152.14 Million | ▼ -11.1 pp |
| 2024 | 60.6% | CN¥496.98 Million | CN¥820.73 Million | CN¥632.76 Million | CN¥135.79 Million | ▼ -12.8 pp |
| 2023 | 73.3% | CN¥476.94 Million | CN¥650.24 Million | CN¥638.75 Million | CN¥161.81 Million | ▼ -24.6 pp |
| 2022 | 98.0% | CN¥634.21 Million | CN¥647.45 Million | CN¥763.54 Million | CN¥129.33 Million | ▲ +25.4 pp |
| 2021 | 72.6% | CN¥360.99 Million | CN¥497.38 Million | CN¥514.46 Million | CN¥153.46 Million | ▼ -1.8 pp |
| 2020 | 74.3% | CN¥330.22 Million | CN¥444.24 Million | CN¥426.28 Million | CN¥96.06 Million | ▲ +25.2 pp |
| 2019 | 49.2% | CN¥112.66 Million | CN¥229.11 Million | CN¥150.46 Million | CN¥37.81 Million | ▲ +7.4 pp |
| 2018 | 41.8% | CN¥81.30 Million | CN¥194.70 Million | CN¥141.72 Million | CN¥60.42 Million | ▼ -16.6 pp |
| 2017 | 58.4% | CN¥85.48 Million | CN¥146.48 Million | CN¥131.64 Million | CN¥46.15 Million | ▼ -7.0 pp |
| 2016 | 65.4% | CN¥76.05 Million | CN¥116.31 Million | CN¥115.27 Million | CN¥39.22 Million | ▼ -3.8 pp |
| 2015 | 69.2% | CN¥67.42 Million | CN¥97.42 Million | CN¥101.21 Million | CN¥33.79 Million | ▲ +25.7 pp |
| 2014 | 43.5% | CN¥23.94 Million | CN¥55.04 Million | CN¥47.30 Million | CN¥23.35 Million | ▼ -6.7 pp |
| 2013 | 50.2% | CN¥32.60 Million | CN¥64.92 Million | CN¥49.66 Million | CN¥17.06 Million | — |